Workflow
Earnings ESP
icon
Search documents
Here's What Investors Must Know Ahead of Jacobs' Q3 Earnings Release
ZACKS· 2025-08-04 16:16
Key Takeaways Jacobs is expected to report Q3 EPS of $1.56, down 20.4% YOY, on $3.07B in revenues, down 27.6%.Global macro headwinds, FX impact and inflation may weigh on the Infrastructure and PA Consulting segments.Cost streamlining initiatives could partially offset margin pressures from labor and IT investments.Jacobs Solutions, Inc. (J) is slated to report third-quarter fiscal 2025 results on Aug. 5, before the opening bell.In the last reported quarter, the company’s adjusted earnings topped the Zacks ...
Runway Growth's Q2 Earnings Coming Up: What's in Store?
ZACKS· 2025-08-04 16:11
Core Insights - Runway Growth Finance Corp. (RWAY) is expected to report second-quarter 2025 results on August 7, with anticipated revenue decline and earnings increase year-over-year [1][8] - The company has a weak earnings surprise history, lagging the Zacks Consensus Estimate in three of the last four quarters [2] Earnings & Sales Projections - The Zacks Consensus Estimate for RWAY's earnings is 39 cents, reflecting a 5.4% increase from the prior-year quarter [3] - The consensus estimate for sales is $34 million, indicating a slight decline [3] Factors Impacting Earnings - The Federal Reserve's decision to keep interest rates unchanged at 4.25-4.5% during Q2 2025 likely benefited RWAY's interest income due to higher loan yields [4] - RWAY has been experiencing rising expenses due to investments in venture growth stage companies, which are expected to have elevated operating costs in the second quarter [4] Earnings Whispers - The quantitative model does not predict an earnings beat for RWAY, as it lacks a positive Earnings ESP and a Zacks Rank better than 3 [5] - RWAY currently holds a Zacks Rank of 3 [6] Performance of Other Finance Stocks - Moody's reported adjusted earnings of $3.56 per share, exceeding the Zacks Consensus Estimate of $3.44, with an 8.5% year-over-year growth [7] - Moelis & Company reported adjusted earnings of 53 cents per share, significantly improving from 18 cents in the prior-year quarter, supported by revenue growth despite increased expenses [9]
Excelerate Energy (EE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ZACKS· 2025-08-04 15:00
Core Viewpoint - The market anticipates Excelerate Energy (EE) will report a year-over-year increase in earnings driven by higher revenues for the quarter ended June 2025, with a consensus EPS estimate of $0.32, reflecting a 23.1% increase, and revenues expected to reach $245.41 million, up 33.9% from the previous year [1][3]. Earnings Expectations - The upcoming earnings report is scheduled for August 11, and the stock may rise if the actual results exceed expectations, while a miss could lead to a decline [2]. - The consensus EPS estimate has been revised down by 1.05% over the last 30 days, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4][12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that Excelerate Energy has a negative Earnings ESP of -6.35%, suggesting a lower likelihood of beating the consensus EPS estimate [12]. - The company currently holds a Zacks Rank of 3 (Hold), which complicates predictions regarding an earnings beat [12]. Historical Performance - In the last reported quarter, Excelerate Energy exceeded the expected EPS of $0.39 by delivering $0.49, resulting in a surprise of +25.64% [13]. - Over the past four quarters, the company has surpassed consensus EPS estimates three times [14]. Industry Comparison - Constellation Energy Corporation, another player in the alternative energy sector, is expected to report earnings of $1.83 per share for the same quarter, reflecting an 8.9% year-over-year increase, with revenues projected at $5.06 billion, down 7.6% from the previous year [18][19]. - Constellation Energy's consensus EPS estimate has been revised up by 5.5% in the last 30 days, but it also has an Earnings ESP of 0%, making predictions about beating the consensus EPS challenging [19][20].
Bitdeer Technologies Group (BTDR) Expected to Beat Earnings Estimates: Should You Buy?
ZACKS· 2025-08-04 15:00
Company Overview - Bitdeer Technologies Group (BTDR) is expected to report a quarterly loss of $0.19 per share, reflecting a year-over-year decline of 733.3% [3] - Revenues are anticipated to be $80.62 million, down 18.8% from the same quarter last year [3] Earnings Estimates and Revisions - The consensus EPS estimate has been revised 25.58% lower in the last 30 days, indicating a reassessment by analysts [4] - The Most Accurate Estimate for Bitdeer is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +3.51% [12] Earnings Surprise Prediction - A positive Earnings ESP reading suggests a likely earnings beat, especially when combined with a Zacks Rank of 3 [10][12] - Bitdeer has a Zacks Rank of 3, indicating a potential to exceed the consensus EPS estimate [12] Historical Performance - In the last reported quarter, Bitdeer was expected to post a loss of $0.48 per share but actually reported a loss of -$0.37, achieving a surprise of +22.92% [13] - Over the past four quarters, Bitdeer has only beaten consensus EPS estimates once [14] Industry Context - In the Zacks Technology Services industry, Amprius Technologies (AMPX) is expected to report a loss of $0.08 per share, which represents a year-over-year change of +38.5% [18] - Amprius's revenue is projected to be $12.92 million, up 285.7% from the previous year, with a positive Earnings ESP of +4% [19][20]
Journey Medical Corporation (DERM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
ZACKS· 2025-08-04 15:00
The market expects Journey Medical Corporation (DERM) to deliver a year-over-year increase in earnings on flat revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, ...
Earnings Preview: Ellington Credit (EARN) Q2 Earnings Expected to Decline
ZACKS· 2025-08-04 15:00
Core Viewpoint - Ellington Credit (EARN) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ended June 2025, which could significantly influence its near-term stock price depending on how actual results compare to consensus estimates [1][2]. Earnings Expectations - The consensus estimate for Ellington Credit's quarterly earnings is $0.21 per share, reflecting a year-over-year decrease of 41.7%. Revenues are projected to be $9.68 million, representing a substantial increase of 148.2% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly altered their initial projections during this period [4]. Earnings Surprise Prediction - The Most Accurate Estimate for Ellington Credit aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%. The stock currently holds a Zacks Rank of 2, complicating predictions of an earnings beat [12]. Historical Performance - In the last reported quarter, Ellington Credit was expected to post earnings of $0.27 per share but delivered $0.26, resulting in a surprise of -3.70%. Over the past four quarters, the company has exceeded consensus EPS estimates three times [13][14]. Industry Comparison - Another player in the REIT and Equity Trust industry, Ready Capital (RC), is expected to report a loss of $0.01 per share for the same quarter, indicating a year-over-year change of -114.3%. Its revenues are expected to decline by 24.8% to $38.32 million, with a recent 5.9% downward revision in the consensus EPS estimate [18][19].
Will Gevo, Inc. (GEVO) Report Negative Earnings Next Week? What You Should Know
ZACKS· 2025-08-04 15:00
Company Overview - Gevo, Inc. (GEVO) is expected to report a year-over-year increase in earnings due to higher revenues for the quarter ended June 2025, with a consensus outlook indicating a quarterly loss of $0.06 per share, representing a 33.3% improvement from the previous year [1][3] - Revenues are anticipated to reach $43.69 million, reflecting a significant increase of 730.6% compared to the same quarter last year [3] Earnings Expectations - The earnings report is scheduled for release on August 11, and if the results exceed expectations, the stock may experience upward movement; conversely, a miss could lead to a decline [2] - The consensus EPS estimate has been revised down by 11.11% over the last 30 days, indicating a reassessment by analysts [4] Earnings Surprise Prediction - The Zacks Earnings ESP (Expected Surprise Prediction) model suggests that a positive Earnings ESP reading indicates a likely earnings beat, particularly when combined with a strong Zacks Rank [10] - For Gevo, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +27.27%, although the stock currently holds a Zacks Rank of 4, complicating predictions of an earnings beat [12] Historical Performance - Gevo has beaten consensus EPS estimates in three out of the last four quarters, with a recent surprise of +10.00% when it reported a loss of -$0.09 per share against an expected loss of -$0.10 [13][14] Industry Context - Ormat Technologies (ORA), another player in the alternative energy sector, is expected to report earnings of $0.37 per share for the same quarter, indicating a year-over-year decline of 7.5%, with revenues projected at $221.71 million, up 4.1% [18][19] - Ormat's consensus EPS estimate has been revised up by 1.9% over the last 30 days, but it currently has an Earnings ESP of -24.66%, making predictions of an earnings beat challenging [19][20]
Earnings Preview: Kolibri Global Energy Inc. (KGEI) Q2 Earnings Expected to Decline
ZACKS· 2025-08-04 15:00
Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings and revenues for Kolibri Global Energy Inc. in the upcoming earnings report, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The consensus estimate for Kolibri Global Energy Inc. is an earnings per share (EPS) of $0.08, reflecting a year-over-year decrease of 27.3% [3]. - Expected revenues are projected at $11.44 million, down 17.8% from the same quarter last year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 18.92%, indicating a reassessment by analysts [4]. - The Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -25.00% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with positive readings being more predictive of earnings beats [9][10]. - Kolibri Global Energy Inc. currently holds a Zacks Rank of 4, making it challenging to predict an earnings beat [12]. Historical Performance - In the last reported quarter, Kolibri Global Energy Inc. exceeded the consensus EPS estimate of $0.13 by delivering $0.16, resulting in a surprise of +23.08% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [14]. Conclusion - Kolibri Global Energy Inc. does not appear to be a strong candidate for an earnings beat based on current estimates and rankings, but other factors should also be considered by investors [17].
Analysts Estimate Mercury Systems (MRCY) to Report a Decline in Earnings: What to Look Out for
ZACKS· 2025-08-04 15:00
Company Overview - Mercury Systems (MRCY) is expected to report a year-over-year decline in earnings due to lower revenues for the quarter ended June 2025, with a consensus EPS estimate of $0.21, reflecting an 8.7% decrease from the previous year [1][3] - Revenues are anticipated to be $241.71 million, down 2.8% from the same quarter last year [3] Earnings Expectations - The upcoming earnings report is scheduled for August 11, and the stock may rise if the actual results exceed expectations, while a miss could lead to a decline [2] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4] Earnings Surprise Prediction - The Most Accurate Estimate for Mercury Systems is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +8.05%, suggesting a more optimistic outlook from analysts [11] - However, the company currently holds a Zacks Rank of 5, which complicates the prediction of an earnings beat [11] Historical Performance - In the last reported quarter, Mercury Systems met the expected EPS of $0.06, resulting in no surprise [12] - Over the past four quarters, the company has beaten consensus EPS estimates three times [13] Industry Comparison - Curtiss-Wright (CW), a peer in the Aerospace - Defense Equipment industry, is expected to report an EPS of $3.13 for the same quarter, indicating a year-over-year increase of 17.2% [17] - Revenues for Curtiss-Wright are projected to be $850.49 million, up 8.4% from the previous year, with a positive Earnings ESP of +0.67% and a Zacks Rank of 2, suggesting a likely earnings beat [18][19]
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q2 Earnings? What You Should Know
ZACKS· 2025-08-04 15:00
Company Overview - Taysha Gene Therapies, Inc. (TSHA) is expected to report a year-over-year increase in earnings due to higher revenues for the quarter ended June 2025, with a consensus outlook indicating a quarterly loss of $0.07 per share, representing a 22.2% improvement from the previous year [1][3] - Revenues are anticipated to reach $1.72 million, reflecting a 55% increase compared to the same quarter last year [3] Earnings Estimates and Trends - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly altered their initial projections [4] - The Most Accurate Estimate for Taysha Gene Therapies is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -14.29%, suggesting a bearish outlook from analysts [12] Earnings Surprise Prediction - A positive Earnings ESP is generally a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [10] - Taysha Gene Therapies currently holds a Zacks Rank of 2, but the negative Earnings ESP complicates the prediction of an earnings beat [12] Historical Performance - In the last reported quarter, Taysha Gene Therapies was expected to post a loss of $0.08 per share and did so, resulting in no surprise [13] - Over the past four quarters, the company has beaten consensus EPS estimates two times [14] Industry Context - Amphastar Pharmaceuticals (AMPH), another player in the Zacks Medical - Generic Drugs industry, is expected to report earnings per share of $0.71 for the same quarter, indicating a year-over-year decline of 24.5% [18] - Revenues for Amphastar are projected to be $169.84 million, down 6.9% from the previous year, with an Earnings ESP of -11.97% [19][20]